Skip to main content

CORRECTION

J. pharm. pharm. sci., 18 December 2023
Volume 26 - 2023 | https://doi.org/10.3389/jpps.2023.12042

Corrigendum: Applications of exhaled breath condensate analysis for drug monitoring and bioequivalence study of inhaled drugs

Nastaran Hashemzadeh,Nastaran Hashemzadeh1,2Elaheh Rahimpour,Elaheh Rahimpour1,3Abolghasem Jouyban, Abolghasem Jouyban1,4*
  • 1Pharmaceutical Analysis Research Center and Faculty of Pharmacy, Tabriz University of Medical Sciences, Tabriz, Iran
  • 2Research Center for Pharmaceutical Nanotechnology, Tabriz University of Medical Sciences, Tabriz, Iran
  • 3Infectious and Tropical Diseases Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
  • 4Pharmaceutical Sciences Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran

A Corrigendum on
Applications of exhaled breath condensate analysis for drug monitoring and bioequivalence study of inhaled drugs

by Hashemzadeh N, Rahimpour E and Jouyban A (2022). J Pharm Pharm Sci. 25:391–401. doi: 10.18433/jpps33121

In the original article, there was a mistake in Table 1 as published. The order of the titles of the 2nd and 3rd columns have been reversed. The corrected form is that the title of the 2nd column is read as “EBC Conc.”, and that of the 3rd column as “Plasma Conc.”. The corrected column titles are marked with red font in the following Table.

TABLE 1
www.frontiersin.org

TABLE 1. An overview of drug concentrations in EBC and plasma samples, along with some details of the determination procedures.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way.

Keywords: exhaled breath condensate, bioequivalence, pharmacodynamic, pharmacokinetic, inhalers

Citation: Hashemzadeh N, Rahimpour E and Jouyban A (2023) Corrigendum: Applications of exhaled breath condensate analysis for drug monitoring and bioequivalence study of inhaled drugs. J. Pharm. Pharm. Sci 26:12042. doi: 10.3389/jpps.2023.12042

Received: 13 September 2023; Accepted: 30 November 2023;
Published: 18 December 2023.

Edited by:

Fakhreddin Jamali, Alberta Innovates–Health Solutions, Canada

Copyright © 2023 Hashemzadeh, Rahimpour and Jouyban. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Abolghasem Jouyban, ajouyban@hotmail.com, jouyban@tbzmed.ac.ir

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.